Price Alert

Boston Scientific Corpora... (BSX)

NYSE: BSX · Real-Time Price · USD

104.16

1.66 (1.62%)

At close: Aug 14, 2025, 3:59 PM

104.50

0.33%

Pre-market: Aug 15, 2025, 07:18 AM EDT

Boston Scientific Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	725M	414M	2.5B	2.91B	2.33B	865M	952M	426M	570M	928M	338M	276M	325M	1.93B	1.95B	2.67B	2.02B
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	655M	555M	532M	589M	429M	413M	427M	421M	385M	407M	381M	376M	399M	412M	434M	616M	643M
Other Long-Term Assets	732M	749M	684M	546M	737M	679M	732M	728M	697M	707M	834M	791M	552M	563M	594M	603M	664M
Receivables	2.69B	2.56B	2.5B	2.4B	2.3B	2.23B	2.1B	2.13B	2.08B	1.97B	1.87B	1.92B	1.87B	1.78B	1.67B	1.68B	1.63B
Inventory	2.87B	2.81B	2.75B	2.61B	2.56B	2.48B	2.4B	2.25B	2.05B	1.87B	1.79B	1.75B	1.74B	1.61B	1.6B	1.43B	1.41B
Other Current Assets	756M	831M	673M	755M	672M	622M	740M	773M	712M	731M	885M	874M	889M	799M	793M	776M	855M
Total Current Assets	7.33B	6.92B	8.76B	8.99B	8.19B	6.51B	6.5B	5.89B	5.7B	5.76B	5.14B	5.08B	5.07B	6.32B	6.23B	6.76B	6.1B
Property-Plant & Equipment	3.84B	3.74B	3.5B	3.37B	3.33B	3.3B	3.08B	2.98B	2.88B	2.83B	2.66B	2.65B	2.69B	2.69B	2.52B	2.49B	2.46B
Goodwill & Intangibles	23.91B	23.77B	20.79B	19.81B	20.2B	20.39B	19.46B	19.72B	19.33B	18.82B	18.91B	19.23B	19.53B	18.11B	18.05B	16.66B	16.86B
Total Long-Term Assets	32.8B	32.48B	29.32B	28.12B	28.48B	28.62B	27.54B	27.72B	27.19B	26.71B	26.8B	27.1B	27.27B	25.91B	25.65B	24.41B	24.8B
Total Assets	40.14B	39.4B	38.08B	37.11B	36.67B	35.14B	34.04B	33.6B	32.89B	32.47B	31.95B	32.19B	32.34B	32.23B	31.88B	31.17B	30.9B
Account Payables	1B	960M	907M	906M	921M	942M	929M	899M	868M	862M	803M	732M	696M	794M	674M	689M	615M
Deferred Revenue	306M	306M	290M	284M	280M	266M	246M	242M	231M	220M	216M	222M	212M	208M	160M	141M	139M
Short-Term Debt	777M	1.78B	1.65B	1.58B	1.08B	531M	513M	559M	510M	20M	20M	170M	238M	261M	261M	262M	13M
Other Current Liabilities	439M	491M	1.66B	1.63B	1.62B	1.92B	1.63B	1.62B	482M	1.64B	1.5B	1.75B	1.97B	629M	1.93B	2.06B	1.76B
Total Current Liabilities	5.06B	6.4B	5.91B	5.58B	4.92B	4.93B	4.58B	4.56B	4.08B	3.8B	3.55B	3.88B	4.28B	4.27B	4.02B	4.07B	3.39B
Long-Term Debt	10.41B	8.84B	9.23B	8.99B	9.53B	8.57B	8.38B	8.49B	8.49B	8.91B	8.56B	8.8B	9.06B	8.8B	8.81B	8.84B	9.08B
Other Long-Term Liabilities	1.21B	1.14B	1.14B	1.12B	1.22B	1.27B	1.16B	1.23B	1.34B	1.4B	1.29B	1.35B	1.34B	1.55B	1.63B	1.55B	1.75B
Total Long-Term Liabilities	12.64B	10.99B	11.21B	10.92B	11.59B	10.67B	10.34B	10.55B	10.7B	11.09B	10.76B	11.05B	11.33B	11.33B	11.39B	11.15B	11.79B
Total Liabilities	17.69B	17.39B	17.12B	16.5B	16.5B	15.61B	14.91B	15.12B	14.78B	14.9B	14.31B	14.94B	15.6B	15.61B	15.41B	15.23B	15.18B
Total Debt	11.71B	11.15B	11.26B	10.94B	11B	9.49B	9.3B	9.45B	9.37B	9.28B	8.93B	9.33B	9.68B	9.45B	9.46B	9.46B	9.44B
Common Stock	17M	17M	17M	17M	17M	17M	17M	17M	17M	17M	17M	17M	17M	17M	17M	17M	17M
Retained Earnings	3.35B	2.67B	2.11B	1.64B	1.31B	819M	315M	-189M	-450M	-750M	-876M	-1.05B	-1.3B	-1.39B	-1.47B	-1.88B	-2.05B
Comprehensive Income	-28M	275M	-128M	164M	133M	49M	231M	208M	178M	269M	532M	433M	222M	263M	238M	237M	254M
Shareholders Equity	22.21B	21.77B	20.71B	20.37B	19.93B	19.28B	18.89B	18.23B	17.85B	17.57B	17.64B	17.25B	16.73B	16.62B	16.46B	15.94B	15.72B
Total Investments	655M	555M	532M	589M	429M	413M	427M	421M	385M	407M	381M	376M	399M	412M	434M	616M	643M